glucagon vs insulin aspart
According to this portal's Publishing Organization, this page was last reviewed in August 2026 against our methodology. Figures and extracts on this site, including tables above 1,000 rows when the corpus is that large, are the publisher's responsibility.
Side-by-side comparison of glucagon and insulin aspart. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
minor Known Drug Interaction
Drugs That May Decrease the Blood Glucose Lowering Effect of NOVOLOG Drugs: Atypical antipsychotics (e.g., olanzapine and clozapine), corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, progestogens (e.g., in oral contraceptives), protease inhibitors, somatropin, sympathomimetic agents (e.g., albuterol, epinephrine, terbutaline), and thyroid hormones. • Drugs that may decrease the blood glucose lowering effect: atypical antipsychotics, corticosteroids, danazol, diuretics, estrogens, glucagon, isoniazid, niacin, oral...
Baqsimi, GlucaGen
NovoLog, Fiasp
Glucagon is a medicine that helps raise your blood sugar if it gets too low. It can also be used to temporarily slow down your digestive system for certain medical tests.
NovoLog (insulin aspart) is a rapid-acting insulin that helps control blood sugar in people with diabetes. It works quickly to lower blood sugar levels after meals.
Glucagon is used to treat very low blood sugar in adults and children who have diabetes. It can also be used to help with some X-ray tests in adults. It does this by slowing down the movement of your stomach and intestines.
NovoLog is used to improve blood sugar control in adults and children with diabetes. Diabetes is a condition where your body doesn't make enough insulin or can't use insulin properly, leading to high blood sugar. This medicine helps to lower your blood sugar levels.
Glucagon works by telling your liver to release stored sugar into your blood. This raises your blood sugar level quickly. It also relaxes the muscles in your stomach and intestines.
NovoLog is a man-made form of insulin that works like the insulin your body naturally makes. It helps sugar (glucose) move from your blood into your cells, where it can be used for energy. This lowers the amount of sugar in your blood.
- • Nausea
- • Vomiting
- • Headache
- • Dizziness
- • Weakness
- • Headache
- • Accidental injury
- • Nausea
- • Diarrhea
- • Low blood sugar
- Dyspnoea 354
- Acute Kidney Injury 313
- Hypotension 286
- Hypoglycaemia 268
- Condition Aggravated 244
- Blood Glucose Increased 10,424
- Nausea 3,724
- Blood Glucose Decreased 3,344
- Fatigue 2,664
- Dyspnoea 2,553
You should not take this medicine if you have a tumor in your adrenal gland called pheochromocytoma. It can cause a large increase in blood pressure. Also, you should not take it if you have a tumor called insulinoma, as it can cause low blood sugar. Do not take if you are allergic to glucagon.
Never share your NovoLog FlexPen, FlexTouch, PenFill cartridge, or PenFill cartridge device with anyone else, even if the needle is changed. Sharing insulin pens or cartridges can spread blood-borne diseases. Changes in your insulin regimen should be made carefully under medical supervision. Low blood sugar can be life-threatening. Monitor your blood sugar regularly. Fluid retention and heart failure can occur if you take NovoLog with thiazolidinediones (TZDs).
Studies haven't shown any risk to the baby during pregnancy. Glucagon is not expected to cause harm to a breastfeeding infant because it will be broken down in the baby's stomach.
Tell your doctor if you are pregnant or plan to become pregnant. Good control of diabetes is important during pregnancy for both you and your baby. Discuss the best way to manage your blood sugar with your doctor.
Also Compare, Nearby Drugs
Compare insulin aspart with
How to Read This glucagon vs insulin aspart Comparison
glucagon is classified in the Glucagon (Hypoglycemia Rescue) drug class, while insulin aspart sits within the Rapid-Acting Insulin class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, glucagon has 1,465 submissions while insulin aspart has 22,709. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. These two drugs have a known minor interaction flagged in FDA labeling, attributed to glucagon acts to raise blood sugar, which directly opposes the way insulin works to lower it. this makes the insulin less effective at controlling your sugar levels.. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for glucagon or insulin aspart.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.